Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes

Daniel M. Ihnat, Joseph L Mills

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Endovascular therapy (EVT) has increasingly become the initial clinical option for treatment of lower extremity peripheral arterial disease (PAD), not only for patients with claudication, but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of EVT for PAD are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective, randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of EVT techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcome of EVT in patients with diabetes. The purpose of the present report is to succinctly review and objectively analyze available data regarding the results of EVT in patients with diabetes.

Original languageEnglish (US)
JournalJournal of Vascular Surgery
Volume52
Issue number3 SUPPL.
DOIs
StatePublished - Sep 2010

Fingerprint

Arterial Occlusive Diseases
Peripheral Arterial Disease
Therapeutics
Benchmarking
Endovascular Procedures
Limb Salvage
Life Tables
Treatment Failure
Lower Extremity
Ischemia
Extremities

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Medicine(all)

Cite this

Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. / Ihnat, Daniel M.; Mills, Joseph L.

In: Journal of Vascular Surgery, Vol. 52, No. 3 SUPPL., 09.2010.

Research output: Contribution to journalArticle

@article{4dc166207720424691b6b58c478b07c3,
title = "Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes",
abstract = "Endovascular therapy (EVT) has increasingly become the initial clinical option for treatment of lower extremity peripheral arterial disease (PAD), not only for patients with claudication, but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of EVT for PAD are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective, randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of EVT techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcome of EVT in patients with diabetes. The purpose of the present report is to succinctly review and objectively analyze available data regarding the results of EVT in patients with diabetes.",
author = "Ihnat, {Daniel M.} and Mills, {Joseph L}",
year = "2010",
month = "9",
doi = "10.1016/j.jvs.2010.06.014",
language = "English (US)",
volume = "52",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes

AU - Ihnat, Daniel M.

AU - Mills, Joseph L

PY - 2010/9

Y1 - 2010/9

N2 - Endovascular therapy (EVT) has increasingly become the initial clinical option for treatment of lower extremity peripheral arterial disease (PAD), not only for patients with claudication, but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of EVT for PAD are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective, randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of EVT techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcome of EVT in patients with diabetes. The purpose of the present report is to succinctly review and objectively analyze available data regarding the results of EVT in patients with diabetes.

AB - Endovascular therapy (EVT) has increasingly become the initial clinical option for treatment of lower extremity peripheral arterial disease (PAD), not only for patients with claudication, but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of EVT for PAD are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective, randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of EVT techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcome of EVT in patients with diabetes. The purpose of the present report is to succinctly review and objectively analyze available data regarding the results of EVT in patients with diabetes.

UR - http://www.scopus.com/inward/record.url?scp=77956238208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956238208&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2010.06.014

DO - 10.1016/j.jvs.2010.06.014

M3 - Article

C2 - 20804939

AN - SCOPUS:77956238208

VL - 52

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 3 SUPPL.

ER -